A professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology, David Low, will pursue an innovative research project for global health and development titled “Strategy for development of enteric pathogen-specific phage”. His research will focus on a new way for the medical world to deal with serious bacterial pathogens which are becoming resistant to many once-powerful antibiotics. Kenny Slaught notes that, “He will engineer phage to selectively target and destroy several pathogenic bacteria to prevent enteric diseases in infants”.